glp-1 camp Unlocking the multifaceted roles of GLP-1: Physiological functions and therapeutic potential GLP-1 Reporter Cells | Incretin
Description
The program is currently scheduled to run through December 2027
The FDA does not approve compounded versions of semaglutide or tirzepatide and has issued warnings about them in 2026
SADI-S produced 3.48 higher odds of type 2 diabetes remission (OR 3.48
Hailey-Hailey Disease HHD, also known as benign familial pemphigus, is a rare autosomal dominant disorder that affects keratinocyte adhesion
This platform starts with a custom home cage where mice can live continuously, but which is outfitted with an array of continuous sensors, a running wheel, and food and water dispensers that are easily monitored
